Your browser doesn't support javascript.
loading
In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis.
Venugopala, Katharigatta N; Tratrat, Christophe; Pillay, Melendhran; Chandrashekharappa, Sandeep; Al-Attraqchi, Omar Husham Ahmed; Aldhubiab, Bandar E; Attimarad, Mahesh; Alwassil, Osama I; Nair, Anroop B; Sreeharsha, Nagaraja; Venugopala, Rashmi; Morsy, Mohamed A; Haroun, Michelyne; Kumalo, Hezekiel M; Odhav, Bharti; Mlisana, Koleka.
Afiliación
  • Venugopala KN; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Tratrat C; Department of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South Africa.
  • Pillay M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Chandrashekharappa S; Department of Microbiology, National Health Laboratory Services, KZN Academic Complex, Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.
  • Al-Attraqchi OHA; Institute for Stem Cell Biology and Regenerative Medicine, NCBS, TIFR, Bangalore 560 065, India.
  • Aldhubiab BE; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman 19392, Jordan.
  • Attimarad M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Alwassil OI; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Nair AB; Department of Pharmaceutical Sciences, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Sreeharsha N; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Venugopala R; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Morsy MA; Department of Public Health Medicine, University of KwaZulu-Natal, Howard College Campus, Durban 4001, South Africa.
  • Haroun M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Kumalo HM; Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt.
  • Odhav B; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Kingdom of Saudi Arabia.
  • Mlisana K; Department of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Medical School, Durban 4001, South Africa.
Drug Des Devel Ther ; 14: 1027-1039, 2020.
Article en En | MEDLINE | ID: mdl-32214795
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirimidinonas / Diseño de Fármacos / Nucleósido-Fosfato Quinasa / Inhibidores Enzimáticos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Prognostic_studies Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirimidinonas / Diseño de Fármacos / Nucleósido-Fosfato Quinasa / Inhibidores Enzimáticos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Prognostic_studies Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article